跳至主要内容
临床试验/EUCTR2019-001843-37-NL
EUCTR2019-001843-37-NL进行中(未招募)1 期

Imaging of tumour microenvironment in patients with oropharyngeal head and neck squamous cell carcinoma using RGD PET/CT imaging. - PIVOT study

Radboud University Medical Center0 个研究点目标入组 20 人开始时间: 2019年6月4日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - Patients with a histologically proven OHNSCC;
  • - P-16 immunohistochemical analysis to determine HPV status of the tumour;
  • - A primary tumour lesion with a diameter of at least 1.0 cm concluded from a diagnostic CT, MRI or FDG PET/CT scan within 4 weeks prior to intake;
  • - Planned chemoradiotherapy as primary treatment;
  • - Age of at least 18 years;
  • - Ability to provide written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • - Contra-indication for (PET/)CT: Pregnancy; Breast-feeding; Severe claustrophobia.
  • - Contra-indication for administration of iodine-containing contrast agents.
  • - Other serious illness, e.g. history of malignancies
  • - Estimated creatinine clearance = 30 mL/min according to the Cockcroft-Gault formula

研究者

相似试验